Skip to main content
Log in

Expression of HIV-1nefin yeast causes membrane perturbation and release of the myristylated Nef protein

  • Original Paper
  • Published:
Journal of Biomedical Science

Abstract

The human immunodeficiency virus type 1 (HIV-1) Nef protein is essential for AIDS pathogenesis, but its function remains highly controversial. During stresses such as growth in the presence of copper or at elevated temperature, myristylated Nef is released from yeast cells and, after extended culture in stationary phase, it accumulates in the supernatant as a dense membranous material that can be centrifuged into a discrete layer above the cell pellet. This material is unique to Nef-producing cells and represents a convenient source of Nef that may have application in further biological studies. Within the yeast cell, electron microscopic examination shows that Nef localises in novel, membrane-bound bodies. These data support the evidence for a role of Nef in membrane perturbation and suggest that there may be a similar localisation for myristylated Nef in HIV-1 infected cells.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Adachi A, Gendelman HE, Koenig S, Folks T, Willey R, Rabson A, Martin MA. Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious clone. J Virol 59:284–291;1986.

    PubMed  Google Scholar 

  2. Allan JS, Coligan JE, Lee T-H, McLane MF, Kanki PJ, Groopman JE, Essex M. A new HTLV-III/LAV encoded antigen detected by antibodies from AIDS patients. Science 230:810–813;1985.

    PubMed  Google Scholar 

  3. Azad AA, Failla P, Lucantoni A, Bentley J, Mardon C, Wolfe A, Fuller K, Hewish D, Sengupta S, Sankovich S, Grgacic E, McPhee D, Macreadie I. Large-scale production and characterization of recombinant human immunodeficiency virus type 1 Nef. J Gen Virol 75:651–655;1994.

    PubMed  Google Scholar 

  4. Barnham KJ, Monks SA, Hinds MG, Azad AA, Norton RS. Solution structure of a polypeptide from the N terminus of the HIV protein Nef. Biochemistry 36:5970–5980;1997.

    Article  PubMed  Google Scholar 

  5. Benichou S, Bomsel M, Bodeus M, Durand H, Doute M, Letourneur F, Camonis J, Benarous R. Physical interaction of the HIV-1 Nef protein with beta-COP, a component of non-clathrin-coated vesicles essential for membrane traffic. J Biol Chem 269:30073–30076;1994.

    PubMed  Google Scholar 

  6. Bodeus M, Marie-Cardine A, Bougeret C, Ramos-Morales F, Benarous R. In vitro binding and phosphorylation of human immunodeficiency virus type 1 Nef protein by serine/threonine protein kinase. J Gen Virol 76:1337–1344;1995.

    PubMed  Google Scholar 

  7. Bukovsky AA, Dorfman T, Weimann A, Gottlinger HG. Nef association with human immunodeficiency virus type 1 virions and cleavage by the viral protease. J Virol 71:1013–1018;1997.

    PubMed  Google Scholar 

  8. Coates K, Cooke SJ, Mann DA, Harris MPG. Protein kinase C-mediated phosphorylation of HIV-1 nef in human cell lines. J Biol Chem 272:12289–12294;1997.

    Article  PubMed  Google Scholar 

  9. Curtain CC, Separovic F, Rivett D, Kirkpatrick A, Waring AJ, Gordon LM, Azad AA. Fusogenic activity of amino-terminal region of HIV type 1 Nef protein. AIDS Res Hum Retroviruses 10:1231–1240;1994.

    PubMed  Google Scholar 

  10. Curtain CC, Lowe MG, Arunagiri CK, Mobley PW, Macreadie IG, Azad AA. Cytolytic activity of amino-terminal region of HIV type 1 Nef protein. AIDS Res Hum Retroviruses 14:1213–1220;1997.

    Google Scholar 

  11. Deacon NJ, Tsykin A, Solomon A, Smith K, Ludford-Menting M, Hooker DJ, McPhee D, Greenway AL, Ellett A, Chatfield C, Lawson VA, Crowe S, Maerz A, Sonza S, Learmont J, Sullivan JS, Cunningham A, Dwyer D, Dowton D, Mills J. Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients. Science 270:988–991;1995.

    Google Scholar 

  12. Fermin CD, Garry RF. Membrane alterations linked to early interactions of HIV with the cell surface. Virology 191:941–946;1992.

    Article  PubMed  Google Scholar 

  13. Franchini G, Robert-Guroff M, Ghrayeb J, Chang NT, Wong-Staal F. Cytoplasmic localization of the HTLV-III 3′ orf protein in cultured T cells. Virology 155:593–599;1986.

    Article  PubMed  Google Scholar 

  14. Foti M, Mangasarian A, Piguet V, Lew DP, Krause K-H, Trono D, Carpentier J-L. Nefmediated clathrin-coated pit formation. J Cell Biol 139:37–47;1997.

    Article  PubMed  Google Scholar 

  15. Fujii Y, Nishino Y, Nakaya T, Tokunaga K, Ikuta K. Expression of human immunodeficiency virus type 1 Nef antigen on the surface of acutely and persistently infected human T cells. Vaccine 11:1240–1246;1993.

    Article  PubMed  Google Scholar 

  16. Fujii Y, Otake K, Fujita Y, Yamamoto N, Nagai Y, Tashiro M, Adachi A. Clustered localization of oligomeric Nef protein of human immunodeficiency virus type 1 on the cell surface. FEBS Lett 395:257–261;1996.

    Article  PubMed  Google Scholar 

  17. Fujii Y, Otake K, Tashiro M, Adachi A. In vitro cytocidal effects of human immunodeficiency virus type 1 Nef on unprimed human CD4+ T cells without MHC restriction. J Gen Virol 77:2943–2951;1996.

    PubMed  Google Scholar 

  18. Geleziunas R, Miller MD, Greene WC. Unravelling the function of HIV type 1 Nef. AIDS Res Hum Retroviruses 12:1579–1582;1996.

    PubMed  Google Scholar 

  19. Greenway A, McPhee D. Nef—the Machiavelli of cellular activation. Res Virol 148:58–64;1997.

    Article  PubMed  Google Scholar 

  20. Guy B, Kieny MP, Riviere Y, Le Peuch C, Dott K, Girad M, Montagnier L, Lecocq J-P. HIV F/3′orf encodes a phosphorylated GTP-binding protein resembling an oncogene product. Nature 330:266–269;1987.

    Article  PubMed  Google Scholar 

  21. Guy B, Rivière Y, Dott K, Regnault A, Kieny MP. Mutational analysis of the HIV Nef protein. Virology 176:413–425;1990.

    Article  PubMed  Google Scholar 

  22. Hammes SR, Dixon EP, Malim MH, Cullen BR, Greene WC. Nef protein of human immunodeficiency virus type 1: Evidence against its role as a transcriptional inhibitor. Proc Natl Acad Sci USA 86:9549–9553;1989.

    PubMed  Google Scholar 

  23. Harris M. From negative factor to a critical role in virus pathogenesis: The changing fortunes of Nef. J Gen Virol 77:2379–2392;1996.

    PubMed  Google Scholar 

  24. Hayakawa T, Miyazaki T, Misumi Y, Kobayashi M, Fujisawa Y. Myristoylation-dependent membrane targeting and release of the HTLV-I Gag precursor, Pr53gag, in yeast. Gene 119:273–277;1992.

    Article  PubMed  Google Scholar 

  25. Kaminchik J, Bashan N, Itach A, Sarver N, Gorecki M, Panet A. Genetic characterization of human immunodeficiency virus type 1nef gene products translated in vitro and expressed in mammalian cells. J Virol 65:583–588;1991.

    PubMed  Google Scholar 

  26. Kaminchik J, Margalit R, Yaish S, Drummer H, Amit B, Sarver N, Gorecki M, Panet A. Cellular distribution of HIV type 1 Nef protein: Identification of domains in Nef required for association with membrane and detergent-insoluble cellular matrix. AIDS Res Hum Retroviruses 10:1003–1010;1994.

    PubMed  Google Scholar 

  27. Kestler HW III, Ringler DJ, Mori K, Panicali DL, Sehgal PK, Daniel MD, Desrosiers RC. Importance of thenef gene for maintenance of high virus loads and for development of AIDS. Cell 65:651–662;1991.

    Article  PubMed  Google Scholar 

  28. Kienzle N, Bachmann M, Muller WE, Muller-Lantzsch N. Expression and cellular localization of the Nef protein from human immunodeficiency virus-1 in stably transfected B-cells. Arch Virol 124:123–132;1992.

    Article  PubMed  Google Scholar 

  29. Kienzle N, Enders M, Buck M, Siakkou H, Jahn S, Petzold G, Schneweis KE, Bachmann M, Muller WE, Muller-Lantzsch N. Expression of the HIV-1 Nef protein in the baculovirus system: Investigation of anti-Nef antibodies response in human sera and subcellular localization of Nef. Arch Virol 126:293–301;1992.

    Article  PubMed  Google Scholar 

  30. Kirchoff F, Greenough TC, Brettler DB, Sullivan JL, Desrosiers RC. Brief report: Absence of intactnef sequences in a long-term survivor with progressive HIV-1 infection. N Engl J Med 332:228–232;1995.

    Article  PubMed  Google Scholar 

  31. Kohleisen B, Neumann M, Herrmann R, Brack-Werner R, Krohn KJE, Ovod V, Ranki A, Erfle V. Cellular localization of Nef expressed in persistently HIV-1-infected low-producer astrocytes. AIDS 6:1427–1436;1992.

    PubMed  Google Scholar 

  32. Luo T, Foster JL, Garcia JV. Molecular determinants of Nef function. J Biomed Sci 4:132–138;1997.

    PubMed  Google Scholar 

  33. Macreadie IG, Ward AC, Failla P, Grgacic E, McPhee D, Azad AA. Expression of HIV-1nef in yeast: The 27 kDa Nef protein is myristylated and fractionates with the nucleus. Yeast 9:565–573;1993.

    Article  PubMed  Google Scholar 

  34. Macreadie IG, Castelli LA, Failla P, Azad AA. Yeast-derived HIV-1 Nef protein lacks G-protein activities. Mol Biol (Life Sci Adv) 12:99–105;1993.

    Google Scholar 

  35. Macreadie IG, Castelli LA, Lucantoni A, Azad AA. Stress-and sequence-dependent release into the culture medium of HIV-1 Nef produced inSaccharomyces cerevisiae. Gene 162:239–243;1995.

    Article  PubMed  Google Scholar 

  36. Macreadie IG, Lowe MG, Curtain CC, Hewish DR, Azad AA. Cytotoxicity resulting from addition of HIV-1 Nef N-terminal peptides to yeast and bacterial cells. Biochem Biophys Res Commun 232:707–711;1997.

    Article  PubMed  Google Scholar 

  37. Matsuura Y, Maekawa M, Hattori S, Ikegami N, Hayashi A, Yamazaki S, Morita C, Takebe Y. Purification and characterization of human immunodeficiency virus type 1 Nef gene product expressed by a recombinant baculovirus. Virology 184:580–586;1991.

    Article  PubMed  Google Scholar 

  38. McKimm-Breschkin JL. The use of tetramethylbenzidine for solid phase immunoassays. J Immunol Methods 135:277–280;1990.

    Article  PubMed  Google Scholar 

  39. Ovod V, Lagerstedt A, Ranki A, Gombert FO, Spohn R, Tahtinen M, Jung G, Krohn KJE. Immunological variation and immunohistochemical localization of HIV-1 Nef demonstrated with monoclonal antibodies. AIDS 6:25–34;1992.

    PubMed  Google Scholar 

  40. Pandori MW, Fitch NJ, Craig HM, Richman DD, Spina CA, Guatelli JC. Producer-cell modification of human immunodeficiency virus type 1: Nef is a virion protein. J Virol 70:4283–4290;1996.

    PubMed  Google Scholar 

  41. Sanfridson A, Hester S, Doyle C. Nef proteins encoded by human and simian immunodeficiency viruses induce the accumulation of endosomes and lysosomes in human T cells. Proc Natl Acad Sci USA 94:873–878;1997.

    Article  PubMed  Google Scholar 

  42. Sawai ET, Baur AS, Peterlin BM, Levy JA, Cheng-Mayer C. A conserved domain and membrane targeting of Nef from HIV and SIV are required for association with a cellular serine kinase activity. J Biol Chem 270:15307–15314;1995.

    Article  PubMed  Google Scholar 

  43. Welker R, Kottler H, Kalbitzer HR, Krausslich HG. Human immunodeficiency virus type 1 Nef protein is incorporated into virus particles and specifically cleaved by the viral proteinase. Virology 219:228–236;1996.

    Article  PubMed  Google Scholar 

  44. Wiskerchen M, Cheng-Mayer C. HIV-1 Nef association with cellular serine kinase correlates with enhanced virion infectivity and efficient proviral DNA synthesis. Virology 224:292–301;1996.

    Article  PubMed  Google Scholar 

  45. Yu G, Felsted RL. Effect of myristylation on p27nef subcellular distribution and suppression of HIV-LTR transcription. Virology 187:46–55;1992.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Macreadie, I.G., Fernley, R., Castelli, L.A. et al. Expression of HIV-1nefin yeast causes membrane perturbation and release of the myristylated Nef protein. J Biomed Sci 5, 203–210 (1998). https://doi.org/10.1007/BF02253470

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02253470

Key Words

Navigation